Pol Specenier
Impact in
- Otorhinolaryngology top 0.5%
- Head and Neck Cancer Studies
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Peptidase Inhibition and Analysis
- Cancer Cells and Metastasis
Papers in
- Oncology 45
- Peptidase Inhibition and Analysis 11
- Cancer Immunotherapy and Biomarkers 10
- Cancer Diagnosis and Treatment 5
- Colorectal Cancer Treatments and Studies 5
- Cancer-related Molecular Pathways 5
-
- Head and Neck Cancer Studies 32
- Co-authors
- Jan B. Vermorken (8 shared papers)Jan B. Vermorken (22 shared papers)Filip Lardon (10 shared papers)Jan B. Vermorken (6 shared papers)Marc Baay (7 shared papers)Vanessa Deschoolmeester (6 shared papers)Marc Peeters (15 shared papers)Katleen Janssens (1 shared paper)
- Journals
- Expert Review of Anticancer Therapy (9 papers)Annals of Oncology (7 papers)Journal of Clinical Oncology (6 papers)Cancer Chemotherapy and Pharmacology (4 papers)The Oncologist (4 papers)
- Partner nations
- BelgiumUnited StatesItaly
In The Last Decade
Pol Specenier
81 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 93
- Otorhinolaryngology 400
- Oncology 866
- Cancer Research 204
- Genetics 136
- Pulmonary and Respiratory Medicine 352
Countries citing papers authored by Pol Specenier
This map shows the geographic impact of Pol Specenier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pol Specenier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pol Specenier more than expected).
Fields of papers citing papers by Pol Specenier
This network shows the impact of papers produced by Pol Specenier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pol Specenier. The network helps show where Pol Specenier may publish in the future.
Co-authors
The 25 scholars most cited alongside Pol Specenier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 282 | |
| 2 | 2016 | 208 | |
| 3 | 2018 | 173 | |
| 4 | 2010 | 134 | |
| 5 | 2016 | 89 | |
| 6 | 2013 | 75 | |
| 7 | 2013 | 73 | |
| 8 | 2008 | 71 | |
| 9 | 2014 | 52 | |
| 10 | 2018 | 42 | |
| 11 | 2016 | 36 | |
| 12 | 2011 | 35 | |
| 13 | 2008 | 34 | |
| 14 | 2016 | 30 | |
| 15 | 2007 | 28 | |
| 16 | 2014 | 27 | |
| 17 | 2018 | 26 | |
| 18 | Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor. | 2015 | 24 |
| 19 | 2022 | 22 | |
| 20 | 2015 | 22 |
About Pol Specenier
Pol Specenier is a scholar working on Oncology, Otorhinolaryngology, Pulmonary and Respiratory Medicine, Molecular Biology and Surgery, having authored 84 papers that have together received 2.0k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (32 papers), Lung Cancer Treatments and Mutations (15 papers), Peptidase Inhibition and Analysis (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), Melanoma and MAPK Pathways (7 papers), Cancer Diagnosis and Treatment (5 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Otorhinolaryngology (400 citations), Oncology (866 citations), Cancer Research (204 citations), Genetics (136 citations) and Pulmonary and Respiratory Medicine (352 citations). Pol Specenier has collaborated with scholars based in Belgium, United States and Italy. Frequent co-authors include Jan B. Vermorken, Jan B. Vermorken, Filip Lardon, Jan B. Vermorken, Marc Baay, Vanessa Deschoolmeester, Marc Peeters, Katleen Janssens, Ilse Weets and Christophe De Block. Their work appears in journals such as Expert Review of Anticancer Therapy, Annals of Oncology, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.